학술논문
Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program
Document Type
Article
Author
Source
In: Pediatric Blood and Cancer . (Pediatric Blood and Cancer, 1 February 2016, 63(2):276-286)
Subject
Language
English
ISSN
15455017
15455009
15455009